Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness model age related macular degeneration comparing macugen visudyne
Webinar: The End of Significance Testing Share on: Thursday, March 28, 2019 Watch the recording The use of statistical significance testing in epidemiological research Null hypothesis significance testing is not dead, but in this webinar, Ken Rothman …
… preference data. Her area of expertise is survey design, cost-benefit analysis, and discrete-choice modeling. …
… methods and in the implementation of studies assessing the effectiveness of risk minimization measures of drugs … areas of interest include studies on evaluation of cancer-related outcomes associated with the use of drugs, and …
… trials (RCTs) are the gold standard to quantify the effectiveness and safety of medical interventions. …
Webinar: The End of Significance Testing Share on: Thursday, March 28, 2019, 10 - 11am Watch the recording The use of statistical significance testing in epidemiological research Null hypothesis significance testing is not dead, but in this webinar, Ken …
… leading executions of analytic tasks, and writing analysis-related sections for study reports. Mr. Davenport has expertise in conducting statistical methods related to exploratory data analysis, predictive modelling … specifically the Study Day Tabulation and Analysis Data Model. Mr. Davenport continues to gain experience in writing …
… Pharmacoepidemiol Drug Saf. 2018 Jan 11;2018:1-8. Related Services Pharmacoepidemiology and Risk Management …
Incorporating Real-World Evidence Into Your Product Development Transcript: It's critical to understand how to incorporate real-world evidence at every stage of your drug or device development journey. You need to understand where your product fits in the …
… Patients' willingness to accept adverse event and cost trade-offs for reduced risk of non-melanoma skin …
… of the labels granted by the FDA and the EMA for PRO-related endpoints, including feedback on specific outcome … are the main challenges sponsors face when including PRO-related endpoints in cancer clinical research? And how can …